Stroke remains one of the leading causes of death and disability in the United States, but swift recognition of its warning signs can dramatically improve outcomes. Medical experts emphasize that the key to survival is to be alert to sudden changes and to seek immediate treatment.

Inventiva has made its preparatory documents available for a crucial Combined General Meeting on June 30, 2026. This announcement reflects the company’s commitment to providing timely updates on its clinical-stage biopharmaceutical work focusing on MASH therapy.

Oculis Holding AG has embarked on a pioneering effort to tackle dry eye disease using a genotype-based approach. The first patient has been enrolled in the PREDICT-1 registrational trial for Licaminlimab, opening a new chapter in personalized eye care.

China’s top health authority has granted Adcentrx Therapeutics approval to proceed with trials for ADRX-0405, an investigational STEAP1 antibody-drug conjugate aiming to treat late-stage solid tumors, including prostate cancer. Building on progress from its U.S. Phase 1a/1b study, the company aims to broaden the trial’s reach and accelerate patient enrollment by including clinical centers in China.

Eledon Pharmaceuticals has released updated findings from an investigator-initiated islet transplant trial at UChicago Medicine, focusing on the potential of Tegoprubart in treating Type 1 Diabetes. The new data marks a key step forward for transplant-based research in diabetes care.

Upstream Bio is set to deliver additional clinical findings from its Phase 2 VIBRANT trial of verekitug, aimed at treating chronic rhinosinusitis with nasal polyps. The data, which centers on a responder analysis, will be presented at the EAACI 2026 Congress in Istanbul on June 14, 2026.

Cardiolife, a health tech provider from Portugal, is teaming up with Bhutan’s Ministry of Health to implement an AI-powered ECG diagnostics program. With heart issues among Bhutan’s leading causes of death, this nationwide rollout marks a significant step in enhancing the country’s preventive cardiac care.

Texas has expanded an emergency declaration after detecting a flesh-eating parasite known as the New World screwworm. Discovered in a calf roughly 100 miles from San Antonio, this is the first confirmed case in about six decades.

A high-risk multiple myeloma diagnosis transformed one patient’s life in December 2020. Now enrolled in a Phase 2 clinical trial, they continue to experience persistent numbness even after four years of treatment.

More than three decades have passed since one advocate first asked, “What will it take to cure Parkinson’s disease?” Today, much has changed, but the quest continues—and California sits at the core of that pursuit.

A 28-year-old individual unexpectedly faces end-of-life kidney failure, a stark reminder of how easily important bodily warnings can go unnoticed. Originally featured in Newsweek, this account pushes readers to consider the urgency of caring for their own health.

Omnix Medical has begun enrolling patients in a Phase II trial of OMN6, a new antimicrobial compound designed to physically disrupt pathogenic bacteria. This breakthrough approach underscores the potential for a novel treatment pathway that could reshape the landscape of antibacterial therapies.

Savara (Nasdaq: SVRA) has released encouraging long-term Phase 3 data suggesting that patients receiving molgramostim for an autoimmune pulmonary condition continue to see improved lung function and respiratory health. Announced in Langhorne, Pennsylvania, the results spotlight a potential breakthrough for individuals affected by persistent breathing challenges.

Advancements in bladder cancer detection are bringing new possibilities to patient care. With awareness rising, healthcare providers and the public are focusing on better diagnostic methods to improve treatment strategies.

The Center for Human Development confirmed a new case of pertussis, commonly known as whooping cough, in Union County. The announcement underscores the contagious nature of this bacteria-caused respiratory infection and highlights the need for public awareness.

Northern California is seeing an unusual rise in rotavirus infections this season, marked by severe diarrhea and vomiting. Health experts note that children between 3 months and 3 years old are the most affected by this “late-spring surge.”

A new report highlights more than 75 drugs under consideration for Duchenne muscular dystrophy, promising significant progress in patient care. The analysis explores clinical strategies, upcoming therapies, and commercial prospects, signaling a major shift in the DMD landscape.

Two of Climb Bio’s most promising therapies—CLYM116 and budoprutug—will be in the spotlight at the European Renal Association Congress 2026. The company is sharing early safety data and a Phase 2 trial update in Glasgow, Scotland, detailing its mission to advance treatment options for immune-mediated kidney diseases.

The World Health Organization warns that Ebola in the Democratic Republic of Congo is spreading faster than efforts to contain it. Countries bordering the DRC face high risk, spurring the WHO to intensify its operations. Still, officials caution that the epidemic may be growing beyond their current capability to control.

This article presents nine foundational steps designed to support heart-healthy living over the long term. While the full details remain unavailable, it offers a foundation for readers seeking strategies to maintain cardiovascular wellness.

Health care leaders in southern Illinois are urging families to schedule back-to-school physicals and vaccinations well before the new academic year begins. By acting now, parents can manage requirements, avoid a late-season rush, and keep their children’s health on track.